T2 Biosystems, Inc. Gains 35.67%

T2 Biosystems, Inc. (TTOO:NASDAQ) jumped higher at $0.26, representing a gain of 35.7%. On Fri, Oct 06, 2023, TTOO:NASDAQ hit a New 2-Week High of $0.26. The stock appeared on our News Catalysts scanner on Fri, Oct 06, 2023 at 06:16 PM in the 'PRIVATE PLACEMENT' category. From Fri, Sep 22, 2023, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Mon, Sep 18, 2023 at $0.47 with a volume of 424M+.
About T2 Biosystems, Inc. (TTOO:NASDAQ)
T2 Biosystems Inc is an in vitro diagnostic company. It has developed the proprietary platform that enables direct detection of pathogens, biomarkers and other abnormalities across various unpurified patient sample types.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 292.16%
- ParaZero Technologies Ltd. (PRZO:NASDAQ), 79.12%
- T2 Biosystems, Inc. (TTOO:NASDAQ), 35.67%
- Vaccinex, Inc. (VCNX:NASDAQ), 34.11%
- American Oncology Network Inc. (AONC:NASDAQ), 32.06%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 30.99%
- Akso Health Group (AHG:NASDAQ), 29.57%
- ALX Oncology Holdings Inc. (ALXO:NASDAQ), 27.38%
- Elite Education Group International Ltd. (EEIQ:NASDAQ), 27.27%
- Omega Therapeutics Inc. (OMGA:NASDAQ), 25.79%